Jacqueline B. Mehr1†
Esther R. Bennett2†
Julianne L. Price3,4
Nicola L. de Souza5,6,7
Jennifer F. Buckman3,4
Elisabeth A. Wilde8,9
David F. Tate8,9Amy D. Marshall10
Kristen Dams-O'Connor7,11Carrie Esopenko6,7*- 1School of Environmental and Biological Sciences, Rutgers University – New Brunswick, New Brunswick, NJ, United States
- 2School of Social Work, Rutgers University - New Brunswick, New Brunswick, NJ, United States
- 3Department of Kinesiology and Health, Rutgers University - New Brunswick, New Brunswick, NJ, United States
- 4Center of Alcohol and Substance Use Studies, Graduate School of Applied and Professional Psychology, Rutgers University - New Brunswick, New Brunswick, NJ, United States
- 5School of Graduate Studies, Biomedical Sciences, Rutgers Biomedical and Health Sciences, Newark, NJ, United States
- 6Department of Rehabilitation and Movement Sciences, School of Health Professions, Rutgers Biomedical and Health Sciences, Newark, NJ, United States
- 7Department of Rehabilitation and Human Performance, Icahn School of Medicine at Mount Sinai, New York, NY, United States
- 8Department of Neurology, School of Medicine, The University of Utah, Salt Lake City, UT, United States
- 9George E. Wahlen, VA Salt Lake City Healthcare System, Research Care Line, Salt Lake City, UT, United States
- 10Department of Psychology, College of the Liberal Arts, The Pennsylvania State University, State College, PA, United States
- 11Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, United States
Exposure to intimate partner violence (IPV), including physical, sexual, and psychological violence, aggression, and/or stalking, impacts overall health and can have lasting mental and physical health consequences. Substance misuse is common among individuals exposed to IPV, and IPV-exposed women (IPV-EW) are at-risk for transitioning from substance misuse to substance use disorder (SUD) and demonstrate greater SUD symptom severity; this too can have lasting mental and physical health consequences. Moreover, brain injury is highly prevalent in IPV-EW and is also associated with risk of substance misuse and SUD. Substance misuse, mental health diagnoses, and brain injury, which are highly comorbid, can increase risk of revictimization. Determining the interaction between these factors on the health outcomes and quality of life of IPV-EW remains a critical need. This narrative review uses a multidisciplinary perspective to foster further discussion and research in this area by examining how substance use patterns can cloud identification of and treatment for brain injury and IPV. We draw on past research and the knowledge of our multidisciplinary team of researchers to provide recommendations to facilitate access to resources and treatment strategies and highlight intervention strategies capable of addressing the varied and complex needs of IPV-EW.
1. Introduction
It is estimated that one in three women worldwide experiences physical and/or sexual violence from an intimate partner (Devries et al., 2013; Breiding et al., 2014; WHO, 2021). Intimate partner violence-exposed women (IPV-EW) frequently experience negative psychological (Campbell, 2002; Afifi et al., 2009; Fletcher, 2010; Okuda et al., 2011; Brignone et al., 2018; Iovine-Wong et al., 2019) and physiological (Campbell, 2002; Wuest et al., 2008, 2010; Kwako et al., 2011) symptoms, as well as comorbidities such as depression, anxiety, posttraumatic stress disorder (PTSD; Dardis et al., 2021), and suicidal ideation (Alhusen et al., 2015; Brignone et al., 2018; Iovine-Wong et al., 2019; Rasmussen et al., 2021). Substance misuse is also seen after IPV exposure in women (Testa et al., 2003; Pallatino et al., 2019; Ogden et al., 2022). Furthermore, the physical and sexual trauma that often occurs in IPV increases the risk for bodily injuries that can result in chronic pain, as well as head, neck, and/or facial injuries that can cause traumatic brain injury (TBI) or acquired hypoxic–ischemic brain injury as a result of non-fatal strangulation (NFS) or other forms of impeded breathing (Wilbur et al., 2001; Valera and Berenbaum, 2003; Wuest et al., 2008; St Ivany and Schminkey, 2016; Campbell et al., 2022; Walker et al., 2022)1. Large independent literatures have identified interrelationships between IPV exposure history and mental health diagnoses, chronic pain, brain injury, substance misuse, and substance use disorder (SUD; Merkel et al., 2017; Voon et al., 2018; Lutgendorf, 2019; Stone and Rothman, 2019; Campbell et al., 2022; Haag et al., 2022; Ogden et al., 2022; Oram et al., 2022); yet, few studies have attempted to piece together the complex interactions between these variables in a manner that supports frontline clinical strategies that more holistically bolster the quality of life for IPV-EW.
This narrative review begins this process by providing a broad framework for understanding substance use and misuse in IPV-EW to researchers and frontline clinicians. IPV and mental health comorbidities have been thoroughly discussed in the literature (Campbell, 2002; Afifi et al., 2009; Okuda et al., 2011; Brignone et al., 2018), and the varied and complex interplay of these factors on risk of substance misuse and SUD warrants a targeted discussion. Despite the elevated risk for substance misuse and SUD associated with IPV, the causal pathways from IPV to SUD and the interaction between IPV exposure and comorbid mental health diagnoses, pain, and brain injury is not clearly understood. This dearth of research exploring mediating factors in the relationship between IPV and SUD interferes with the development of new treatment targets and improvement of clinical outcomes for IPV-EW. Moreover, it perpetuates common stigmas associated with substance misuse, including the identification of substance users as intractable, “difficult” to treat, and even incurable.
2. The relationship of substance use and IPV exposure
Substance misuse is defined as substance use at high doses or in inappropriate situations. SUD is a diagnosable illness that arises following prolonged substance misuse and that significantly alters health and daily functioning (Campbell, 2002; McLellan, 2017). Substance misuse in IPV-EW has been reported as a means of coping with the physical and emotional pain (Smith et al., 2012; Simonelli et al., 2014; Gezinski et al., 2021). Self-medication, defined in the general population as using alcohol, recreational drugs with analgesic properties, and prescription opioids to treat pain (Alford et al., 2016; Cil et al., 2019; Rogozea et al., 2020), can accelerate the progression from substance use to SUD (Timko et al., 2005; Lehavot et al., 2014; Hogarth et al., 2019); however, the use of psychoactive substances as self-medication is not specific to the IPV community - it is a common pathway to addiction across populations. Moreover, similar to research in other fields that links heavy and frequent use of psychoactive substances to risk of violence and assault, substance misuse and SUD has been shown to also place IPV-EW at an increased risk for future IPV victimization (Kingery et al., 1992; Kilpatrick et al., 1997; Cunningham et al., 2009).
IPV exposure in women may increase the occurrence of risky substance use behaviors. For example, frequent patterns of heavy or binge drinking episodes (Testa and Leonard, 2001; Martino et al., 2005; Weinsheimer et al., 2005; Hink et al., 2015; Ullman and Sigurvinsdottir, 2015) and drinking and driving (Hanson, 2010) have been observed. Elevated rates of illicit substance use (El-Bassel et al., 2005; Gilbert et al., 2012; Hink et al., 2015), misuse of prescription medications (Smith et al., 2012; Hall et al., 2016), and needle sharing for intravenous substance use (Braitstein et al., 2003; Wagner et al., 2009) have also been reported in women exposed to physical or sexual violence relative to non IPV-EW. These risky behaviors contribute to general poor health and increased mortality, even in circumstances where they do not reach criteria for a SUD diagnosis (Patel et al., 2016; Dwyer-Lindgren et al., 2018; Gjersing and Bretteville-Jensen, 2018). For instance, intravenous substance use increases the risk for contracting highly communicable diseases like hepatitis C and human immunodeficiency virus (HIV) as well as other infections (Lake and Kennedy, 2016). In addition, misuse of prescription medications and illicit substances is associated with greater risk of chronic illnesses like pulmonary complications and liver failure (Baltarowich et al., 2018; Nanayakkara and McNamara, 2021).
Diagnostic criteria of SUD are stronger correlates of IPV than consumption patterns alone (Cafferky et al., 2018). IPV-EW are more likely than non IPV-EW to transition from misuse to SUD and have greater SUD symptom severity (Liebschutz et al., 2002; La Flair et al., 2012; Hobkirk et al., 2015). Estimates of 24%–75% (Paone et al., 1992; El-Bassel et al., 2000; Beijer et al., 2018) of women report lifetime IPV exposure at SUD treatment intake. Similarly, the prevalence of SUD in IPV-EW is greater than in the general population (Schneider et al., 2009; Smith et al., 2012; Stone and Rothman, 2019). In one study, half of women presenting to a shelter after IPV exposure report recent alcohol use, almost all of whom met criteria for alcohol use disorder (AUD; Poole et al., 2008). An overrepresentation of IPV-EW in substance use treatment facilities, and vice versa, is one indication that an optimal time to intervene for both IPV and SUD may be when women seek help for either IPV or SUD (Bennett and O’Brien, 2007; Macy and Goodbourn, 2012).
Treatment-seeking samples, however, are not always representative of the population. Self-selection occurs as treatment-seekers are limited to those who are willing and able to attain medical help. Large scale community-based studies may therefore better describe rates of SUD and IPV in the general population. Although the prevalence of co-occurring SUD and IPV are lower in the community than treatment seeking samples, the associative patterns between the two remain strong (Afifi et al., 2009, 2012). Even when controlling for a number of sociodemographic variables and psychiatric comorbidities, women in community samples who report exposure to IPV have a greater occurrence of substance misuse and SUD than those without IPV exposure (Afifi et al., 2012; La Flair et al., 2012; Salom et al., 2015). Interestingly, though, the SUD and IPV associations are often substance-specific and vary by the type of violence exposure, as will be explained in the following sections.
2.1. The IPV-SUD temporal relationship
The temporal relationship between IPV and SUD can be difficult to parse as IPV exposure and substance use often occur concurrently (Caetano et al., 2000; Nowotny and Graves, 2013; Simonelli et al., 2014), and retrospective substance use can be difficult to confirm. Most findings describe either cross-sectional or single-time point data, as opposed to time-dependent relationships (Testa and Leonard, 2001; Weinsheimer et al., 2005; Hanson, 2010; Smith et al., 2012; Hink et al., 2015; Ullman and Sigurvinsdottir, 2015; Hohman et al., 2017), although a handful of longitudinal and metanalytic studies have suggested that IPV more often precedes the onset of substance misuse/SUD (Kilpatrick et al., 1997; Testa et al., 2003; El-Bassel et al., 2005; Carbone-López et al., 2006; Devries et al., 2014; Øverup et al., 2015). While some research indicates that current misuse of alcohol (Devries et al., 2014) and other drugs (Kilpatrick et al., 1997; Moore et al., 2008) is associated with future IPV, the current review will focus on substance use patterns that emerge after experiencing IPV (El-Bassel et al., 2005).
2.2. Types and patterns of substance use following IPV
Alcohol is arguably the most commonly used psychoactive substance among IPV-EW (El-Bassel et al., 2003; Finney, 2004; Afifi et al., 2012; Kraanen et al., 2014), unsurprising as it is also the most commonly used psychoactive substance in the world (Peacock et al., 2018). Alcohol has acute analgesic properties (Neddenriep et al., 2019; Boissoneault et al., 2020), making it a particularly frequent target of misuse among individuals experiencing physical pain. In-lab alcohol administration paradigms have shown a dose–response relationship between increased blood alcohol content (BAC) and decreased pain intensity, but only once BAC surpasses the legal limit (0.08%; Thompson et al., 2017). This suggests that the use of alcohol as an analgesic requires repeated high doses, a pattern of use that increases the odds of developing AUD (Patrick et al., 2021). Testa et al. (2003) and Øverup et al. (2015) both found a high incidence of heavy/problem drinking episodes in the 1–2 year period following IPV exposure in IPV-EW relative to individuals who did not report exposure to IPV. This was supported by a 2014 meta-analysis that reported a positive association between IPV exposure and subsequent alcohol use in IPV-EW (Devries et al., 2014) although the authors emphasized the need for more multi-wave longitudinal projects due to heterogeneity of measurement and the lack of control for confounds including partner’s alcohol consumption. These studies point to the importance of considering alcohol misuse in the context of pain self-management, particularly in women who may be less likely or able to seek medical treatment for injuries sustained as the result of an IPV-related assault. Reframing alcohol use through this lens may help clinical treatment providers to restructure alcohol-related conversations to reduce stigma and shame.
Among IPV-EW who are able and seek medical care, opiates are prescribed at a staggering rate - up to four times higher than in the general population (Stene et al., 2012; Stone and Rothman, 2019). Although prescription medication use can serve to manage physical pain due to physical abuse (Poole et al., 2008; Cole and Logan, 2010; Hemsing et al., 2016; Stone and Rothman, 2019; Williams et al., 2020), there is a lack of support for long term opiate management of pain, as chronic opiate use decreases pain tolerance (Compton, 1994; Younger et al., 2008) and increases risk of physical dependence (Compton et al., 2003; Raith and Hochhaus, 2004). Further, a prospective medical chart review found that women reporting IPV exposure had higher prescription rates than the general population for opiates and benzodiazepines (Stene et al., 2012), both of which have high addiction potential and can be very dangerous when taken together (Gudin et al., 2013; Afzal and Kiyatkin, 2019). Over-prescription also can drive a transition from prescription opiate to illicit opiate use, like heroin, among treatment-seeking individuals in the general population (Hoffman et al., 2017; Volkow et al., 2019) and non-prescription opiate use has been documented among some IPV-EW (Stone and Rothman, 2019; Williams et al., 2020) and as a consequence of IPV exposure (El-Bassel et al., 2005).
Consistent with alcohol and opiate use patterns, cannabis use disorder is also more prevalent among IPV-EW than in the general population (El-Bassel et al., 2000; Gilbert et al., 2012; Smith et al., 2012). While cannabis has been touted as effective for pain management (Russo et al., 2007; Hill et al., 2017), clinical evidence remains limited, and some argue that cannabis use is more commonly used to cope with psychological as opposed to physical trauma in people exposed to IPV (El-Bassel et al., 2011; Reingle et al., 2012) and a general population of young adults (Bonn-Miller et al., 2008). Cannabis use for stress/coping purposes can increase risk of developing SUD (Hyman and Sinha, 2009) and may be accompanied by a perpetuation of depressive and anxiety disorders and suicidal ideation in adolescents (Copeland et al., 2013). Given the risk for mental health symptoms, such as depression and PTSD, among IPV-EW, and the prevalence of cannabis use in this population, research is needed to explore how cannabis interacts to either exacerbate or ameliorate mental health symptoms (Haney and Evins, 2016; Lowe et al., 2019). Moreover, cannabis use should be considered in context of polysubstance use patterns that can arise from mixing recreational and prescription psychoactive substances. Such multi-drug patterns can exacerbate unsafe and unhealthy behavioral repertoires that can increase risk for revictimization and worsening overall physical and mental health. Thus, although national approval of medicinal and recreational cannabis use is growing, the risk for misuse and dependence in IPV-EW should not be ignored.
IPV-EW have indicated that their substance use can serve as a coping mechanism for the physical, as well as emotional pain of trauma exposure (Øverup et al., 2015; Gezinski et al., 2021). Alcohol and recreational substance use in women is also impacted by partner behavior (Owens et al., 2013; Derrick et al., 2019). In IPV-EW, some perpetrators may coerce or force IPV survivors to use addictive substances (Warsaw and Tinnon, 2018). Added to that is the increased accessibility to addictive prescription medications due to the high likelihood for emergency room visits in this population because of injuries experienced (Kothari and Rhodes, 2006; Rhodes et al., 2011; Hemsing et al., 2016). While reports suggest that a primary driver of substance use in IPV-EW is self-medication, the possibility that both IPV perpetrators and the medical community may exacerbate this behavior warrants significant consideration. Substance users remain highly stigmatized in our society and clinical treatment providers are urged to account for these external factors in the complex needs of IPV-EW.
3. Factors affecting the relationship between IPV exposure and substance use
3.1. Sociodemographics
Age, education, race, and socioeconomic status are established factors in the risk for IPV exposure (Smith et al., 2018). Racial and ethnic minorities experience disproportionate rates of rape, physical violence, or stalking by an intimate partner (CDC, 2017), and over 80% of Indigenous women in the United States have experienced IPV, stalking, or sexual violence (National Institute of Justice, 2016; Rosay, 2016). Racial discrimination produces increased risk for IPV exposure (Cho et al., 2014) and developing mental health issues after violence exposure (Voth Schrag, 2017). Individuals with disabilities also experience higher rates of IPV (Hughes et al., 2011; Plummer and Findley, 2012; García-Cuéllar et al., 2022) and face additional barriers to help-seeking (Plummer and Findley, 2012). Similarly, racial discrimination increases the risk for developing a SUD (Yoo et al., 2010; Otiniano Verissimo et al., 2014; Pro et al., 2018; Matsuzaka and Knapp, 2020), and racial and ethnic minority groups experience more severe consequences related to SUDs including treatment disparities, criminal justice involvement, morbidity, mortality, and violence (Boyd et al., 2003; Smedley et al., 2003; Iguchi et al., 2005; Amaro et al., 2006; Mennis and Stahler, 2016; Matsuzaka and Knapp, 2020). Moreover, structural bias in the media has promulgated stereotypes about SUDs as a personal deficit specific to people of color, which again influences access to, and the quality of SUD treatment provided to minority groups (Matsuzaka and Knapp, 2020).
Poverty and poor economic conditions are both a risk for and consequence of IPV exposure (CDC, 2019; Fernandes-Alcantara, 2019). Socioeconomic mobility can be restricted through physical and psychological trauma by preventing educational attainment and causing job instability; 64% of IPV-EW report that violence exposure hindered their ability to work (McLean and Bocinski, 2017). Likewise, income inequalities can be perpetuated through substance use related stigma in discriminatory employment and housing practices (Earnshaw, 2020). Gender inequality in education, employment, and income further adds to this burden (Niolon et al., 2017), as does overcrowding, high unemployment rates, neighborhood disadvantage, and low social resource capital (Niolon et al., 2017; CDC, 2019). Moreover, because IPV exposure results in various physical and mental health needs, health care utilization costs are often high and many victims pay for services out of pocket or incur medical debt (McLean and Bocinski, 2017). Economic barriers also negatively impact access to quality SUD treatment (Matsuzaka and Knapp, 2020; CDC, 2022) and often delay treatment seeking due to lack of health insurance and/or reliable transportation (Schmidt et al., 2007; Matsuzaka and Knapp, 2020; CDC, 2022). This delay in treatment seeking can impact the severity of substance misuse issues and the progression to SUD (Lewis et al., 2018; Matsuzaka and Knapp, 2020). Finally, it is noteworthy that adverse childhood experiences (ACEs) including childhood physical and sexual abuse, adversity, and a family history of (or witness to) IPV are associated with increased risk for IPV exposure in adulthood as well as increased risk for substance use (LeTendre and Reed, 2017; CDC, 2018; Currie and Tough, 2021; Leza et al., 2021). For frontline care providers, it is important to consider the intersecting effects of sociodemographics on IPV and substance use risk, particularly as such factors affect the breadth and quality of treatment strategies that are accessible to certain populations. These considerations can inform decisions regarding wraparound care and connection to resources.
3.2. Mental health
Exposure to IPV is associated with increased risk for onset of mental health disorders, with incidence rates highest for depression, anxiety, PTSD, and mood disorders (Okuda et al., 2011; Ahmadabadi et al., 2020; Chandan et al., 2020; Mazza et al., 2021). Likewise, SUD demonstrates high comorbidity with mental health conditions and psychiatric disorders (Grant et al., 2015, 2016). Moreover a diagnosis of depression has been associated with subsequent alcohol misuse in IPV-EW (La Flair et al., 2012). Additionally, in IPV-EW recruited from shelter populations and community samples, 60%–90% meet diagnostic criteria for PTSD (Golding, 1999; Dutton et al., 2005, 2006; Woods et al., 2008; Nathanson et al., 2012), and show greater symptom severity than trauma-exposed women who have not experienced IPV (Pico-Alfonso, 2005; Sullivan and Holt, 2008; Woods et al., 2008). In parallel, nearly half of women who develop PTSD following exposure to IPV also develop comorbid SUD (Najavits et al., 2004; Sullivan and Holt, 2008; Sullivan et al., 2012; Najavits and Hien, 2013). Women with a history of physical IPV and comorbid PTSD were nearly 15 times more likely to have days in which they use both alcohol and drugs than IPV-EW without PTSD (Sullivan et al., 2016; McKee and Hilton, 2019). Not surprisingly, the use of alcohol and other drugs to cope with the mental health symptoms following IPV exposure can exacerbate mental health disorders, increase symptom severity, and perpetuate maladaptive coping (Poole et al., 2008; Sullivan et al., 2012; Ullman and Sigurvinsdottir, 2015; Stoicescu et al., 2019). This sets a potentially cyclical relationship between IPV exposure, substance misuse, and mental health problems, which must be considered in all clinical contexts to reduce the potential for worsening mental health outcomes and the risk for revictimization (Gearon and Bellack, 1999; Tol et al., 2019).
3.3. Brain injury and substance use
To-date, IPV-related brain injuries have been vastly understudied, yet the rates of partner-inflicted head trauma and probable brain injury among IPV-EW are estimated to be extremely high. For example, studies suggest that anywhere from 30% to 92% of participants report at least one episode of abuse with either exposure to head or neck trauma and/or probable brain injury (Jackson et al., 2002; Valera and Berenbaum, 2003; St Ivany and Schminkey, 2016; Valera and Kucyi, 2017; Esopenko et al., 2021; Campbell et al., 2022). Another recent scoping review found that the prevalence of head trauma is between 19% and 100% across studies, with the large range being due to varied definitions of head trauma and brain injury as well as varied participant inclusion characteristics (e.g., inclusion of only participants with injuries to the head; Haag et al., 2022).
Repetitive exposure to head trauma is also of significant concern as at least 50% of individuals within these samples report multiple episodes of head, neck, and facial trauma (Wilbur et al., 2001; St Ivany and Schminkey, 2016; Valera and Kucyi, 2017; Zieman et al., 2017). Imporantly, each head, neck, and/or facial trauma that occurs as a result of physical and sexual violence in IPV has the potential to result in a brain injury (Capizzi et al., 2020; Esopenko et al., 2021; Meyer et al., 2021; Saleem et al., 2021). IPV-related TBI can occur due to being punched, kicked, thrown, hit with an object, or shaken, all of which can result in focal and/or diffuse axonal injury (Sheridan and Nash, 2007; Valera et al., 2019). NFS, suffocation, and other forms of impeded breathing occurring as a result of IPV can cause hypoxic–ischemic brain injuries from a lack of, or decrease in, oxygen to the brain (Jackson et al., 2002; Valera and Berenbaum, 2003; Kwako et al., 2011; Haag et al., 2022; Valera et al., 2022). With so many avenues for brain trauma, it is probably unsurprising that estimates suggest that approximately 23 million people are living with IPV-related brain injury in the United States alone (St Ivany and Schminkey, 2016).
In the general population, there is some evidence that substance use increases following brain injury, but other factors, such as premorbid substance use, injury severity, and age at time of injury also affect this relationship (Ponsford et al., 2007; Pagulayan et al., 2016; Kennedy et al., 2017; Merkel et al., 2017; Shiwalkar et al., 2017; Schindler et al., 2021). Moreover, the high prevalence of IPV-related head trauma and probable brain injuries, coupled with other factors discussed above (e.g., comorbid mental health symptoms), likely increases the risk of SUD (Oliverio et al., 2020; Oakley et al., 2021). For example, one study of female veterans who all screened positive for TBI found that only the women who also reported a lifetime history of IPV had a SUD diagnosis (Iverson et al., 2020). In the general population, the neural changes and resulting cognitive and psychological impairments occurring after TBI are strong predictors of substance use, misuse, and development of SUD (Graham and Cardon, 2008; Weil et al., 2016; Beaulieu-Bonneau et al., 2018; Olsen and Corrigan, 2021), and contribute to poorer treatment outcomes (Corrigan and Deutschle, 2008; Graham and Cardon, 2008). However, the cause-and-effect relationship between TBI and substance use is complex and hard to parse as substance use is both a risk factor for, and sequelae of, TBI (Nikoo et al., 2017; Eskander et al., 2020). Nonetheless, there is evidence that brain injury often remains undiagnosed among IPV-EW, as substance misuse and mental health issues mask brain injury symptoms, thereby precluding effective assessment and treatment for brain injury (Banks, 2007; Haag et al., 2022). Undiagnosed brain injury has far-reaching mental and physical health consequences, and failure to identify brain injury in the clinical context could prove detrimental to the long-term outcomes of IPV-EW, by impeding delivery of adequate and effective therapies. (Comper et al., 2005). It also can perpetuate stigmas associated with SUD, such as patients being “difficult” and the disease as being intractable.
4. Facilitating substance use intervention strategies for IPV-EW
4.1. Acknowledging barriers to care
The combined exposure to IPV and SUD creates barriers (i.e., women with SUDs being denied shelter admission) that inhibit access to treatment for either IPV or SUD (Logan and Walker, 2004; Humphreys et al., 2005; Klostermann, 2006; Macy and Goodbourn, 2012). Standard trauma-informed frameworks are not always sufficient to treat the complex needs of IPV survivors who are also coping with substance use problems (Macy and Goodbourn, 2012; Capezza et al., 2015), and SUD treatment facilities rarely screen for IPV exposure (Bennett and Lawson, 1994; Collins et al., 1997; Logan et al., 2002). Another consideration is encouragement or coercion by partners to continue drug use (Gilbert et al., 2001; Simonelli et al., 2014; USDHHS, 2020). For instance, partner opposition to SUD treatment entry poses a barrier to recovery (Amaro and Hardy-Fanta, 1995; USDHHS, 2020), and IPV perpetrators may keep substances around the home and pressure or force their partner to use substances (USDHHS, 2020). Additionally, brain injury-related cognitive and neurobehavioral impairments can make it harder for those with brain injury and IPV exposure to gain access to, stick with, and benefit from standard treatments for SUD (Vungkhanching et al., 2007; Olson-Madden et al., 2012). These barriers, in general SUD samples, have been shown to undermine the likelihood of SUD treatment success (Bates et al., 2006, 2013). Thus, the creation and implementation of treatment options that include cognitive and neurobehavioral support remain urgently needed.
4.2. Screening
Given that mental health diagnoses, including SUD, increase the risk of continued and future victimization (Gearon and Bellack, 1999; Friedman and Loue, 2007), it would be beneficial for all emergency departments and mental health facilities to screen for history of IPV, and associated comorbidities, particularly exposure to head, neck, and facial trauma and probable brain injury, in anyone seeking treatment for these conditions (Waalen et al., 2000; Clark et al., 2008; Rabin et al., 2009; Radcliffe and Gilchrist, 2016; Gilchrist and Hegarty, 2017; Iverson et al., 2020). Likewise, screening for IPV and brain injury in substance use treatment programs is also needed as efficacy is significantly reduced in IPV-EW who are not receiving care and resources related to violence exposure (Capezza et al., 2015). Similarly, screening for SUD in anyone seeking IPV treatment and shelter services not only increases the safety of IPV populations, as research shows SUD is linked with re-victimization, but will also provide timely SUD treatment (Kilpatrick et al., 1997; Capaldi et al., 2012; Simmons et al., 2014, 2017; McKee and Hilton, 2019). Free, validated self-report tools, such as the Alcohol Use Disorders Identification Test (AUDIT; Saunders et al., 1993), the Drug Abuse Screening Test (DAST-10; Skinner, 1982; Bohn et al., 1991), and the Alcohol, Smoking, and Substance Use Involvement Screening Test (ASSIST; Humeniuk et al., 2010) are readily available and can be used to quickly assess alcohol and substance misuse. Health care agencies could also serve a greater number of IPV-EW who need SUD treatment, but who may lack health insurance coverage and/or are financially dependent on an IPV perpetrator (Clark et al., 2008; Foster et al., 2010; Priester et al., 2016), by including an assessment of financial need to ensure access to services regardless of financial limitations (Hageman and George, 2018). Screening processes may best be facilitated by social work staff trained in resource facilitation and could increase the likelihood that basic needs are also met (Macy et al., 2013). Lastly, key stakeholders, including domestic violence and SUD agencies could further improve outcomes by screening and referring IPV-EW for brain injury-related services, as cognitive deficits resulting from brain injury can make a survivor’s physical and emotional healing more difficult (Iverson and Pogoda, 2015; Haag et al., 2022) and, more generally, SUD treatment less efficacious.
4.3. CBT-based interventions
Intervention research shows support for cognitive-behavioral therapies (CBT) as most effective for targeting PTSD, depression, emotional well-being, and substance misuse in IPV groups (Eckhardt et al., 2013; Arroyo et al., 2017). A systematic review and meta-analysis found that CBT-based interventions specifically tailored for the unique needs of IPV survivors resulted in the largest effect sizes for outcomes such as PTSD, depression, and self-esteem with moderate effect size decreases in substance use outcomes (Arroyo et al., 2017). Other recent research demonstrates the efficacy of CBT with interventions such as Helping to Overcome PTSD through Empowerment [HOPE] (Johnson and Zlotnick, 2009). This CBT-based HOPE intervention was developed specifically for IPV-EW who were also residing in a shelter and was shown to reduce the likelihood for revictimization. Cognitive Trauma Therapy for Battered Women (CTT-BW) is another intervention developed to address trauma history, exposure to abuse and abuser reminders, as well as monitoring of negative self-talk and cognitive therapy for guilt (Kubany et al., 2004). CTT-BW showed significant reductions in PTSD and depressive symptoms among IPV-EW that were maintained at 6-month follow-up (Kubany et al., 2004).
4.4. Concurrent IPV/SUD treatment
There is evidence that concurrent IPV services and substance use treatment may be a more effective approach than treating IPV or SUD on their own (Capezza and Najavits, 2012; Macy and Goodbourn, 2012; Capezza et al., 2015). For example, one treatment strategy designed to address both trauma symptoms and SUD, known as Seeking Safety, has been efficacious in reducing SUD and PTSD symptoms (Najavits, 2007) and has been recommended for use with IPV groups (Cohen et al., 2013; McKee and Hilton, 2019). By utilizing one facility with the same team of treatment personnel, coordination is efficient, cost-effective, and there is a greater likelihood that individuals will attend, complete, and benefit from the program (Mueser et al., 2003; Poole et al., 2008; Murphy and Ting, 2010; Capezza et al., 2015; McKee and Hilton, 2019).
4.5. Teaching and strengthening resilience
A crucial consideration for substance use treatment programs for IPV-EW is resilience, a process of positive adaptation despite adverse conditions (Crann and Barata, 2016; Tsirigotis and Łuczak, 2018; Rollero and Speranza, 2020; Gonzalez-Mendez and Hamby, 2021). Resilience is a skill set that promotes beneficial responses to avoid negative outcomes and reduce harmful effects on physical and psychological functioning (Luthar et al., 2000; Humphreys, 2003; Gonzalez-Mendez and Hamby, 2021). Among IPV-EW, higher resilience has been consistently correlated with lower levels of PTSD, depression, anxiety, psychological distress, and risk for substance use (Humphreys, 2003; Anderson et al., 2012; Gonçalves and Matos, 2020). Interventions that can both teach and strengthen resilience have been shown to improve IPV-EW’s confidence, independence, power, and positive social relationships, all of which contribute positive outcomes (Humphreys, 2003; Decker et al., 2020). Research has shown that IPV-EW who employ strategies such as physical activity, creativity, spirituality, introspection, and optimism are more likely to demonstrate greater resilience, positive adaptation, self-efficacy, and healing from abuse (Drumm et al., 2014; López-Fuentes and Calvete, 2015). Similarly, interventions that empower IPV-EW to access and use their strengths (e.g., social resources, help-seeking behaviors, assertiveness, problem-solving skills) enable survivors to respond to partner violence and related sequelae with healthier behavioral strategies, ultimately resulting in a decreased risk for substance use problems (Luthar et al., 2000; Humphreys, 2003; Sani and Pereira, 2020).
Several studies have documented that an increase in resilience is associated with decreased substance use and SUD recovery (Elm et al., 2016; McKinley and Theall, 2021; Yamashita et al., 2021). In fact, one study demonstrated that women with greater resilience, defined as a strong sense of self, an awareness of the abuse, a knowledge of resources, and a future hope, showed more awareness of how their abuser’s and their own substance use contributed to the maintenance of the abusive relationship (Werner-Wilson et al., 2000). This increased awareness is a crucial factor needed for ending the potentially cyclical nature of substance use in IPV (Gutierres and Van Puymbroeck, 2006). In addition, increased resilience is associated with healthier and safer decision making in IPV-EW which supports efforts to reduce risk for revictimization (McFarlane et al., 1997; Humphreys, 2003; Decker et al., 2020; Schaefer et al., 2021). The ability of resilience to reduce physical and psychological distress, while improving overall health, could make it a key target for recovery from SUD (Gorvine et al., 2021). Teaching and strengthening resilience could provide a positive, empowering, and healthy alternative for IPV-EW to obtain relief from the physical pain and psychological trauma symptoms that may be underlying the use of alcohol and other drugs (Hernandez and Mendoza, 2011; Gorvine et al., 2021). With prior research demonstrating the power of resilience to reduce substance use and misuse, future research is necessary to expand the potential for SUD prevention in IPV using the resilience framework (Gorvine et al., 2021; Yamashita et al., 2021).
5. Conclusion
The complex and cyclical relationship between IPV exposure and substance misuse warrants significantly more research and clinical attention, particularly considering that both demonstrate complex interactions with with highly comorbid factors, such as mental health problems and brain injury. Critical next steps include cross-fertilization of ideas, theories, and data from fields such as social work, psychology, neuroscience, addiction, and women’s health. This review presents evidence for an elevated risk for misuse of recreational and prescription substances in this population, but emphasizes a need for clinicians to reframe perspectives on this use to improve outcomes for all IPV-EW. Clinicians are urged to consider substance use in light of physical and emotional pain that often results from violence exposure, and take care to screen for SUDs prior to prescribing potentially addictive medications. Mental health disorders and IPV-related brain injuries are additional factors for clinicians to consider. It is only when substance use, mental health, and brain health are considered together that IPV-EW will gain access to optimal treatment strategies. In the absence of such comprehensive screening, IPV-EW may appear unable or unwilling to affect meaningful change to improve their quality of life, thereby perpetuating the stigma and bias that remains deeply entrenched against IPV survivors and substance users.
The suggested clinical approach, derived from the evidence reviewed, is for concurrent treatment of IPV and SUD, with added infrastructure for mental health and cognitive support to facilitate treatment seeking, treatment gains, and long-term quality of life - both in terms of violence exposure and substance use. Clinicians treating those with IPV should consider SUD, mental health diagnoses, and cognitive impairments in terms of clinical presentation and severity. Likewise, those providing SUD treatment should assess for IPV exposure as well as mental and brain health, as this may strongly alter the optimal treatment path (WHO, 2013). It is acknowledged, however, that such comprehensive screenings are time and resource intensive, and may not be feasible in all contexts. Yet, even for those with limited time and resources, such as emergency department health care providers and shelter workers, building knowledge of these comorbidities is essential for improving outcomes for IPV-EW. Future research should be directed at probing the interplay of SUD, brain injury, mental health, and IPV, as well as testing which screening and recovery protocols provide the best treatment outcomes in IPV-EW experiencing SUD across different contexts.
Author contributions
CE, JB, EW, DT, AM, and KD-O’C were involved in manuscript conceptualization. JM, EB, CE, and JB wrote the initial paper draft. JP and NS provided editorial and conceptual feedback. All authors contributed to the article and approved the submitted version.
Funding
CE, EW, and DT are supported by the National Institutes of Neurological Disorders and Stroke [R01NS115957]. DT is also supported by the and the National Institute of Neurological Disorders and Stroke [R01NS122184; R61NS120249]. JB is supported by a NIH/NIAAA K-award [K02AA025123]. JP is supported through the NIH postdoctoral fellowship training program [T32AA028254]. KD-O’C is supported by the National Institute on Disability, Independent Living, and Rehabilitation [90DPTB0009] and the International Alzheimer’s and Related Dementias Research Portfolio [1RF1NS115268].
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Footnotes
1. ^Brain injury will be used as an umbrella term for IPV-related TBI and/or hypoxic–ischemic brain injury (described in section 3.3).
References
Afifi, T. O., Henriksen, C. A., Asmundson, G. J. G., and Sareen, J. (2012). Victimization and perpetration of intimate partner violence and substance use disorders in a nationally representative sample. J. Nerv. Ment. Dis. 200, 684–691. doi: 10.1097/NMD.0b013e3182613f64
Afifi, T. O., MacMillan, H., Cox, B. J., Asmundson, G. J. G., Stein, M. B., and Sareen, J. (2009). Mental health correlates of intimate partner violence in marital relationships in a nationally representative sample of males and females. J. Interpers. Violence 24, 1398–1417. doi: 10.1177/0886260508322192
Afzal, A., and Kiyatkin, E. A. (2019). Interactions of benzodiazepines with heroin: respiratory depression, temperature effects, and behavior. Neuropharmacology 158:107677. doi: 10.1016/j.neuropharm.2019.107677
Ahmadabadi, Z., Najman, J. M., Williams, G. M., Clavarino, A. M., d’Abbs, P., and Tran, N. (2020). Intimate partner violence and subsequent depression and anxiety disorders. Soc. Psychiatry Psychiatr. Epidemiol. 55, 611–620. doi: 10.1007/s00127-019-01828-1
Alford, D. P., German, J. S., Samet, J. H., Cheng, D. M., Lloyd-Travaglini, C. A., and Saitz, R. (2016). Primary care patients with drug use report chronic pain and Self-medicate with alcohol and other drugs. J. Gen. Intern. Med. 31, 486–491. doi: 10.1007/s11606-016-3586-5
Alhusen, J. L., Frohman, N., and Purcell, G. (2015). Intimate partner violence and suicidal ideation in pregnant women. Arch. Womens Ment. Health 18, 573–578. doi: 10.1007/s00737-015-0515-2
Amaro, H., Arévalo, S., Gonzalez, G., Szapocznik, J., and Iguchi, M. Y. (2006). Needs and scientific opportunities for research on substance abuse treatment among Hispanic adults. Drug Alcohol Depend. 84, S64–S75. doi: 10.1016/j.drugalcdep.2006.05.008
Amaro, H., and Hardy-Fanta, C. (1995). Gender relations in addiction and recovery. J. Psychoactive Drugs 27, 325–337. doi: 10.1080/02791072.1995.10471698
Anderson, K. M., Renner, L. M., and Danis, F. S. (2012). Recovery: resilience and growth in the aftermath of domestic violence. Violence Against Women 18, 1279–1299. doi: 10.1177/1077801212470543
Arroyo, K., Lundahl, B., Butters, R., Vanderloo, M., and Wood, D. S. (2017). Short-term interventions for survivors of intimate partner violence: a systematic review and meta-analysis. Trauma Violence Abuse 18, 155–171. doi: 10.1177/1524838015602736
Baltarowich, L., Miller, J., Hurst, G., Varma, A., Gardner-Gray, J., Pflaum, J., et al. (2018). The changing face of acute liver failure in the wake of the us prescription opioid epidemic: review of 327 cases of acetaminophen-induced acute liver failure over 12 years. Clin. Toxicol. 56, 913–914.
Banks, M. E. (2007). Overlooked but critical: traumatic brain injury as a consequence of interpersonal violence. Trauma Violence Abuse 8, 290–298. doi: 10.1177/1524838007303503
Bates, M. E., Pawlak, A. P., Tonigan, J. S., and Buckman, J. F. (2006). Cognitive impairment influences drinking outcome by altering therapeutic mechanisms of change. Psychol. Addict. Behav. 20, 241–253. doi: 10.1037/0893-164X.20.3.241
Bates, M. E., Buckman, J. F., and Nguyen, T. T. (2013). A role for cognitive rehabilitation in increasing the effectiveness of treatment for alcohol use disorders. Neuropsychol. Rev. 23, 27–47. doi: 10.1007/s11065-013-9228-3
Beaulieu-Bonneau, S., St-Onge, F., Blackburn, M.-C., Banville, A., Paradis-Giroux, A.-A., and Ouellet, M.-C. (2018). Alcohol and drug use before and during the first year after traumatic brain injury. J. Head Trauma Rehabil. 33, E51–E60. doi: 10.1097/HTR.0000000000000341
Beijer, U., Scheffel Birath, C., DeMartinis, V., and Af Klinteberg, B. (2018). Facets of male violence against women with substance abuse problems: women with a residence and homeless women. J. Interpers. Violence 33, 1391–1411. doi: 10.1177/0886260515618211
Bennett, L., and Lawson, M. (1994). Barriers to cooperation between domestic-violence and substance-abuse programs. Fam. Soc. 75, 277–286. doi: 10.1177/104438949407500503
Bennett, L., and O’Brien, P. (2007). Effects of coordinated Services for Drug-Abusing Women who are Victims of intimate partner violence. Violence Against Women 13, 395–411. doi: 10.1177/1077801207299189
Bohn, M. J., Babor, T. F., and Kranzler, H. R. (1991). “Validity of the drug abuse screening test (DAST-10) in inpatient substance abusers” in Problems of Drug Dependence. ed. L. Harris (Bethesda, MD: Department of Health, education, and welfare, public health service, alcohol, drug abuse, and mental health administration, National Institute on Drug Abuse, Division of Research)
Boissoneault, J., Stennett, B., and Robinson, M. E. (2020). Acute alcohol intake alters resting state functional connectivity of nucleus accumbens with pain-related corticolimbic structures. Drug Alcohol Depend. 207:107811. doi: 10.1016/j.drugalcdep.2019.107811
Bonn-Miller, M. O., Vujanovic, A. A., and Zvolensky, M. J. (2008). Emotional Dysregulation: association with coping-oriented marijuana use motives among current marijuana users. Subst. Use Misuse 43, 1653–1665. doi: 10.1080/10826080802241292
Boyd, M. R., Phillips, K., and Dorsey, C. J. (2003). Alcohol and other drug disorders, comorbidity, and violence: comparison of rural African American and Caucasian women. Arch. Psychiatr. Nurs. 17, 249–258. doi: 10.1053/j.apnu.2003.10.003
Braitstein, P., Li, K., Tyndall, M., Spittal, P., O’Shaughnessy, M. V., Schilder, A., et al. (2003). Sexual violence among a cohort of injection drug users. Soc. Sci. Med. 57, 561–569. doi: 10.1016/S0277-9536(02)00403-3
Breiding, M. J., Chen, J., and Black, M. C. (2014). Intimate Partner Violence in the United States – 2010. Atlanta, GA: National Center for Injury Prevention and Control, Centers for Disease Control and Prevention.
Brignone, E., Sorrentino, A. E., Roberts, C. B., and Dichter, M. E. (2018). Suicidal ideation and behaviors among women veterans with recent exposure to intimate partner violence. Gen. Hosp. Psychiatry 55, 60–64. doi: 10.1016/j.genhosppsych.2018.10.006
Caetano, R., Cunradi, C. B., Schafer, J., and Clark, C. L. (2000). Intimate partner violence and drinking patterns among white, Black, and Hispanic couples in the U.S. J. Subst. Abus. 11, 123–138. doi: 10.1016/S0899-3289(00)00015-8
Cafferky, B. M., Mendez, M., Anderson, J. R., and Stith, S. M. (2018). Substance use and intimate partner violence: a meta-analytic review. Psychol. Violence 8, 110–131. doi: 10.1037/vio0000074
Campbell, J. C. (2002). Health consequences of intimate partner violence. Lancet 359, 1331–1336. doi: 10.1016/S0140-6736(02)08336-8
Campbell, J. K., Joseph, A.-L. C., Rothman, E. F., and Valera, E. M. (2022). The prevalence of brain injury among survivors and perpetrators of intimate partner violence and the prevalence of violence victimization and perpetration among people with brain injury: a scoping review. Curr. Epidemiol. Rep. 9, 290–315. doi: 10.1007/s40471-022-00302-y
Capaldi, D. M., Knoble, N. B., Shortt, J. W., and Kim, H. K. (2012). A systematic review of risk factors for intimate partner violence. Partn. Abus. 3, 231–280. doi: 10.1891/1946-6560.3.2.231
Capezza, N. M., and Najavits, L. M. (2012). Rates of trauma-informed counseling at substance abuse treatment facilities: reports from over 10, 000 programs. Psychiatr. Serv. 63, 390–394. doi: 10.1176/appi.ps.201000560
Capezza, N. M., Schumacher, E. C., and Brady, B. C. (2015). Trends in intimate partner violence services provided by substance abuse treatment facilities: findings from a National Sample. J. Fam. Viol. 30, 85–91. doi: 10.1007/s10896-014-9649-7
Capizzi, A., Woo, J., and Verduzco-Gutierrez, M. (2020). Traumatic brain injury: an overview of epidemiology, pathophysiology, and medical management. Med. Clin. North Am. 104, 213–238. doi: 10.1016/j.mcna.2019.11.001
Carbone-López, K., Kruttschnitt, C., and Macmillan, R. (2006). Patterns of intimate partner violence and their associations with physical health, psychological distress, and substance use. Public Health Rep. 121, 382–392. doi: 10.1177/003335490612100406
CDC (2017). National intimate partner and sexual violence survey. U.S. Department of Health & Human Services. Available at: https://www.cdc.gov/violenceprevention/pdf/NISVS-StateReportBook.pdf (Accessed December 11, 2022).
CDC (2018). Adverse childhood experiences resources. U.S. Department of Health & Human Services. Available at: https://www.cdc.gov/violenceprevention/aces/resources.html (Accessed July 27, 2021).
CDC (2019). Risk and protective factors for perpetration. U.S. Department of Health & Human Services. Available at: https://www.cdc.gov/violenceprevention/intimatepartnerviolence/riskprotectivefactors.html (Accessed December 11, 2022).
CDC (2022). Drug overdose deaths rise, disparities widen differences grew by race, ethnicity, and other factors. U.S. Department of Health & Human Services. Available at: https://www.cdc.gov/vitalsigns/overdose-death-disparities/index.html (Accessed December 11, 2022).
Chandan, J. S., Thomas, T., Bradbury-Jones, C., Russell, R., Bandyopadhyay, S., Nirantharakumar, K., et al. (2020). Female survivors of intimate partner violence and risk of depression, anxiety and serious mental illness. Br. J. Psychiatry 217, 562–567. doi: 10.1192/bjp.2019.124
Cho, H., Velez-Ortiz, D., and Parra-Cardona, J. R. (2014). Prevalence of intimate partner violence and associated risk factors among Latinos/as: an exploratory study with three Latino subpopulations. Violence Against Women 20, 1041–1058. doi: 10.1177/1077801214549636
Cil, G., Park, J., and Bergen, A. W. (2019). Self-reported prescription drug use for pain and for sleep and incident frailty. J. Am. Geriatr. Soc. 67, 2474–2481. doi: 10.1111/jgs.16214
Clark, H. W., Power, A. K., Le Fauve, C. E., and Lopez, E. I. (2008). Policy and practice implications of epidemiological surveys on co-occurring mental and substance use disorders. J. Subst. Abus. Treat. 34, 3–13. doi: 10.1016/j.jsat.2006.12.032
Cohen, L. R., Field, C., Campbell, A. N. C., and Hien, D. A. (2013). Intimate partner violence outcomes in women with PTSD and substance use: a secondary analysis of NIDA clinical trials network “women and trauma” multi-site study. Addict. Behav. 38, 2325–2332. doi: 10.1016/j.addbeh.2013.03.006
Cole, J., and Logan, T. K. (2010). Nonmedical use of sedative-hypnotics and opiates among rural and urban women with protective orders. J. Addict. Dis. 29, 395–409. doi: 10.1080/10550887.2010.489453
Collins, J. J., Kroutil, L. A., Roland, E. J., and Moore-Gurrera, M. (1997). “Issues in the linkage of alcohol and domestic violence services” in Recent developments in alcoholism: Volume 13: Alcohol and violence-epidemiology neurobiology psychology family issues recent development in alcoholism. eds. M. Galanter, H. Begleiter, R. Deitrich, R. Fuller, D. Gallant, and D. Goodwin, et al. (Boston, MA: Springer US), 387–405. doi: 10.1007/0-306-47141-8_20
Comper, P., Bisschop, S. M., Carnide, N., and Tricco, A. (2005). A systematic review of treatments for mild traumatic brain injury. Brain Inj. 19, 863–880. doi: 10.1080/02699050400025042
Compton, M. A. (1994). Cold-pressor pain tolerance in opiate and cocaine abusers: correlates of drug type and use status. J. Pain Symptom Manag. 9, 462–473. doi: 10.1016/0885-3924(94)90203-8
Compton, P., Athanasos, P., and Elashoff, D. (2003). Withdrawal hyperalgesia after acute opioid physical dependence in nonaddicted humans: a preliminary study. J. Pain 4, 511–519. doi: 10.1016/j.jpain.2003.08.003
Copeland, J., Rooke, S., and Swift, W. (2013). Changes in cannabis use among young people: impact on mental health. Curr. Opin. Psychiatry 26, 325–329. doi: 10.1097/YCO.0b013e328361eae5
Corrigan, J. D., and Deutschle, J. J. (2008). The presence and impact of traumatic brain injury among clients in treatment for co-occurring mental illness and substance abuse. Brain Inj. 22, 223–231. doi: 10.1080/02699050801938967
Crann, S. E., and Barata, P. C. (2016). The experience of resilience for adult female survivors of intimate partner violence: a phenomenological inquiry. Violence Against Women 22, 853–875. doi: 10.1177/1077801215612598
Cunningham, R. M., Murray, R., Walton, M. A., Chermack, S. T., Wojnar, M., Wozniak, P., et al. (2009). Prevalence of past year assault among inner-city emergency department patients. Ann. Emerg. Med. 53, 814–823.e15. doi: 10.1016/j.annemergmed.2009.01.016
Currie, C. L., and Tough, S. C. (2021). Adverse childhood experiences are associated with illicit drug use among pregnant women with middle to high socioeconomic status: findings from the all our families cohort. BMC Pregnancy Childbirth 21:133. doi: 10.1186/s12884-021-03591-1
Dardis, C. M., Ullman, S. E., Rodriguez, L. M., Waterman, E. A., Dworkin, E. R., and Edwards, K. M. (2021). Bidirectional associations between alcohol use and intimate partner violence and sexual assault victimization among college women. Addict. Behav. 116:106833. doi: 10.1016/j.addbeh.2021.106833
Decker, M. R., Wood, S. N., Hameeduddin, Z., Kennedy, S. R., Perrin, N., Tallam, C., et al. (2020). Safety decision-making and planning mobile app for intimate partner violence prevention and response: randomised controlled trial in Kenya. BMJ Glob. Health 5:e002091. doi: 10.1136/bmjgh-2019-002091
Derrick, J. L., Wittkower, L. D., and Pierce, J. D. (2019). Committed relationships and substance use: recent findings and future directions. Curr. Opin. Psychol. 30, 74–79. doi: 10.1016/j.copsyc.2019.03.002
Devries, K. M., Child, J. C., Bacchus, L. J., Mak, J., Falder, G., Graham, K., et al. (2014). Intimate partner violence victimization and alcohol consumption in women: a systematic review and meta-analysis. Addiction 109, 379–391. doi: 10.1111/add.12393
Devries, K. M., Mak, J. Y. T., García-Moreno, C., Petzold, M., Child, J. C., Falder, G., et al. (2013). The global prevalence of intimate partner violence against women. Science 340, 1527–1528. doi: 10.1126/science.1240937
Drumm, R., Popescu, M., Cooper, L., Trecartin, S., Seifert, M., Foster, T., et al. (2014). “God just brought me through it”: spiritual coping strategies for resilience among intimate partner violence survivors. Clin. Soc. Work. J. 42, 385–394. doi: 10.1007/s10615-013-0449-y
Dutton, M. A., Green, B. L., Kaltman, S. I., Roesch, D. M., Zeffiro, T. A., and Krause, E. D. (2006). Intimate partner violence, PTSD, and adverse health outcomes. J. Interpers. Violence 21, 955–968. doi: 10.1177/0886260506289178
Dutton, M. A., Kaltman, S., Goodman, L. A., Weinfurt, K., and Vankos, N. (2005). Patterns of intimate partner violence: correlates and outcomes. Violence Vict. 20, 483–497. doi: 10.1891/vivi.2005.20.5.483
Dwyer-Lindgren, L., Bertozzi-Villa, A., Stubbs, R. W., Morozoff, C., Shirude, S., Unützer, J., et al. (2018). Trends and patterns of geographic variation in mortality from substance use disorders and intentional injuries among US counties, 1980-2014. JAMA 319, 1013–1023. doi: 10.1001/jama.2018.0900
Earnshaw, V. A. (2020). Stigma and substance use disorders: a clinical, research, and advocacy agenda. Am. Psychol. 75, 1300–1311. doi: 10.1037/amp0000744
Eckhardt, C. I., Murphy, C. M., Whitaker, D. J., Sprunger, J., Dykstra, R., and Woodard, K. (2013). The effectiveness of intervention programs for perpetrators and victims of intimate partner violence. Partn. Abus. 4, 196–231. doi: 10.1891/1946-6560.4.2.196
El-Bassel, N., Gilbert, L., Schilling, R., and Wada, T. (2000). Drug abuse and partner violence among women in methadone treatment. J. Fam. Violence 15, 209–228. doi: 10.1023/A:1007532917759
El-Bassel, N., Gilbert, L., Witte, S., Wu, E., and Chang, M. (2011). Intimate partner violence and HIV among drug-involved women: contexts linking these two epidemics—challenges and implications for prevention and treatment. Subst. Use Misuse 46, 295–306. doi: 10.3109/10826084.2011.523296
El-Bassel, N., Gilbert, L., Witte, S., Wu, E., Gaeta, T., Schilling, R., et al. (2003). Intimate partner violence and substance abuse among minority women receiving care from an inner-city emergency department. Womens Health Issues 13, 16–22. doi: 10.1016/S1049-3867(02)00142-1
El-Bassel, N., Gilbert, L., Wu, E., Go, H., and Hill, J. (2005). Relationship between drug abuse and intimate partner violence: a longitudinal study among women receiving methadone. Am. J. Public Health 95, 465–470. doi: 10.2105/AJPH.2003.023200
Elm, J. H. L., Lewis, J. P., Walters, K. L., and Self, J. M. (2016). “I’m in this world for a reason”: resilience and recovery among American Indian and Alaska native two-spirit women. J. Lesbian Stud. 20, 352–371. doi: 10.1080/10894160.2016.1152813
Eskander, N., Prabhudesai, S., Imran, H., Ceren Amuk, O., and Patel, R. S. (2020). Alcohol use disorder increases risk of traumatic brain injury-related hospitalization: insights from 3.8 million children and adolescent inpatients. Cureus 12:e8740. doi: 10.7759/cureus.8740
Esopenko, C., Meyer, J., Wilde, E. A., Marshall, A. D., Tate, D. F., Lin, A. P., et al. (2021). A global collaboration to study intimate partner violence-related head trauma: the ENIGMA consortium IPV working group. Brain Imaging Behav. 15, 475–503. doi: 10.1007/s11682-020-00417-0
Fernandes-Alcantara, A. L. (2019). Family violence prevention and services act (FVPSA): Background and funding. Congressional Research Service (CRS). Available at: https://crsreports.congress.gov/product/pdf/R/R42838 (Accessed December 11, 2022).
Finney, A. (2004). Alcohol and intimate partner violence: key findings from the research. Great Britain Home Office Research Development and Statistics Directorate Available at: https://www.ojp.gov/ncjrs/virtual-library/abstracts/alcohol-and-intimate-partner-violence-key-findings-research (Accessed June 10, 2021).
Fletcher, J. (2010). The effects of intimate partner violence on health in young adulthood in the United States. Soc. Sci. Med. 70, 130–135. doi: 10.1016/j.socscimed.2009.09.030
Foster, S., LeFauve, C., Kresky-Wolff, M., and Rickards, L. D. (2010). Services and supports for individuals with co-occurring disorders and long-term homelessness. J. Behav. Health Serv. Res. 37, 239–251. doi: 10.1007/s11414-009-9190-2
Friedman, S. H., and Loue, S. (2007). Incidence and prevalence of intimate partner violence by and against women with severe mental illness. J Womens Health (Larchmt) 16, 471–480. doi: 10.1089/jwh.2006.0115
García-Cuéllar, M. M., Pastor-Moreno, G., Ruiz-Pérez, I., and Henares-Montiel, J. (2022). The prevalence of intimate partner violence against women with disabilities: a systematic review of the literature. Disabil. Rehabil., 1–8. doi: 10.1080/09638288.2022.2025927
Gearon, J. S., and Bellack, A. S. (1999). Women with schizophrenia and co-occurring substance use disorders: an increased risk for violent victimization and HIV. Community Ment. Health J. 35, 401–419. doi: 10.1023/a:1018778310859
Gezinski, L. B., Gonzalez-Pons, K. M., and Rogers, M. M. (2021). Substance use as a coping mechanism for survivors of intimate partner violence: implications for safety and service accessibility. Violence Against Women 27, 108–123. doi: 10.1177/1077801219882496
Gilbert, L., El-Bassel, N., Chang, M., Wu, E., and Roy, L. (2012). Substance use and partner violence among urban women seeking emergency care. Psychol. Addict. Behav. 26, 226–235. doi: 10.1037/a0025869
Gilbert, L., El-Bassel, N., Rajah, V., Foleno, A., and Frye, V. (2001). Linking drug-related activities with experiences of partner violence: a focus group study of women in methadone treatment. Violence Vict. 16, 517–536.
Gilchrist, G., and Hegarty, K. (2017). Tailored integrated interventions for intimate partner violence and substance use are urgently needed. Drug Alcohol Rev. 36, 3–6. doi: 10.1111/dar.12526
Gjersing, L., and Bretteville-Jensen, A. L. (2018). Patterns of substance use and mortality risk in a cohort of “hard-to-reach” polysubstance users. Addiction 113, 729–739. doi: 10.1111/add.14053
Golding, J. M. (1999). Intimate partner violence as a risk factor for mental disorders: a meta-analysis. J. Fam. Violence 14, 99–132. doi: 10.1023/A:1022079418229
Gonçalves, M., and Matos, M. (2020). Mental health of multiple victimized immigrant women in Portugal: does resilience make a difference? J. Hum. Behav. Soc. Environ. 30, 353–368. doi: 10.1080/10911359.2019.1685423
Gonzalez-Mendez, R., and Hamby, S. (2021). Identifying Women’s strengths for promoting resilience after experiencing intimate partner violence. Violence Vict. 36, 29–44. doi: 10.1891/VV-D-18-00178
Gorvine, M. M., Haynes, T. F., Marshall, S. A., Clark, C. J., Lovelady, N. N., and Zaller, N. D. (2021). A qualitative exploration of Women’s lives and resilience in substance use disorder recovery. Integr Med (Encinitas). 20, 20–29.
Graham, D. P., and Cardon, A. L. (2008). An update on substance use and treatment following traumatic brain injury. Ann. N. Y. Acad. Sci. 1141, 148–162. doi: 10.1196/annals.1441.029
Grant, B. F., Goldstein, R. B., Saha, T. D., Chou, S. P., Jung, J., Zhang, H., et al. (2015). Epidemiology of DSM-5 alcohol use disorder: results from the National Epidemiologic Survey on alcohol and related conditions III. JAMA Psychiat. 72, 757–766. doi: 10.1001/jamapsychiatry.2015.0584
Grant, B. F., Saha, T. D., Ruan, W. J., Goldstein, R. B., Chou, S. P., Jung, J., et al. (2016). Epidemiology of DSM-5 drug use disorder: results from the National Epidemiologic Survey on alcohol and related conditions-III. JAMA Psychiat. 73, 39–47. doi: 10.1001/jamapsychiatry.2015.2132
Gudin, J. A., Mogali, S., Jones, J. D., and Comer, S. D. (2013). Risks, management, and monitoring of combination opioid, benzodiazepines, and/or alcohol use. Postgrad. Med. 125, 115–130. doi: 10.3810/pgm.2013.07.2684
Gutierres, S. E., and Van Puymbroeck, C. (2006). Childhood and adult violence in the lives of women who misuse substances. Aggress. Violent Behav. 11, 497–513. doi: 10.1016/j.avb.2006.01.010
Haag, H., Jones, D., Joseph, T., and Colantonio, A. (2022). Battered and brain injured: traumatic brain injury among women survivors of intimate partner violence—a scoping review. Trauma Violence Abuse 23, 1270–1287. doi: 10.1177/1524838019850623
Hageman, S. A., and George, D. M. M. S. (2018). Social workers, intimate partner violence (IPV), and client financial concerns. J. Soc. Serv. Res. 44, 391–399. doi: 10.1080/01488376.2018.1476288
Hall, M. T., Golder, S., Higgins, G. E., and Logan, T. K. (2016). Nonmedical prescription opioid use among victimized women on probation and parole. Addict. Behav. 53, 113–119. doi: 10.1016/j.addbeh.2015.10.008
Haney, M., and Evins, A. E. (2016). Does cannabis cause, exacerbate or ameliorate psychiatric disorders? An oversimplified debate discussed. Neuropsychopharmacology 41, 393–401. doi: 10.1038/npp.2015.251
Hanson, M. J. (2010). Health behavior in adolescent women reporting and not reporting intimate partner violence. J Obstet Gynecol Neonatal Nurs 39, 263–276. doi: 10.1111/j.1552-6909.2010.01138.x
Hemsing, N., Greaves, L., Poole, N., and Schmidt, R. (2016). Misuse of prescription opioid medication among women: a scoping review. Pain Res. Manag. 2016:e1754195. doi: 10.1155/2016/1754195
Hernandez, V. R., and Mendoza, C. T. (2011). Shame resilience: a strategy for empowering women in treatment for substance abuse. J. Soc. Work. Pract. Addict. 11, 375–393. doi: 10.1080/1533256X.2011.622193
Hill, K. P., Palastro, M. D., Johnson, B., and Ditre, J. W. (2017). Cannabis and pain: a clinical review. Cannabis Cannabinoid Res. 2, 96–104. doi: 10.1089/can.2017.0017
Hink, A. B., Toschlog, E., Waibel, B., and Bard, M. (2015). Risks go beyond the violence: association between intimate partner violence, mental illness, and substance abuse among females admitted to a rural level I trauma center. J. Trauma Acute Care Surg. 79, 709–716. doi: 10.1097/TA.0000000000000856
Hobkirk, A. L., Watt, M. H., Green, K. T., Beckham, J. C., Skinner, D., and Meade, C. S. (2015). Mediators of interpersonal violence and drug addiction severity among methamphetamine users in Cape Town, South Africa. Addict. Behav. 0, 167–171. doi: 10.1016/j.addbeh.2014.11.030
Hoffman, L. A., Lewis, B., and Nixon, S. J. (2017). Opioid misuse trends in treatment seeking populations: revised prescription opioid policy and temporally corresponding changes. Subst. Use Misuse 52, 1850–1858. doi: 10.1080/10826084.2017.1316291
Hogarth, L., Martin, L., and Seedat, S. (2019). Relationship between childhood abuse and substance misuse problems is mediated by substance use coping motives, in school attending south African adolescents. Drug Alcohol Depend. 194, 69–74. doi: 10.1016/j.drugalcdep.2018.10.009
Hohman, M., Barker, M., and Woodruff, S. (2017). What lies beneath: trauma events, PTSD, and alcohol misuse in driving under the influence program clients. J. Soc. Work. Pract. Addict. 17, 95–113. doi: 10.1080/1533256X.2017.1302885
Hughes, R. B., Lund, E. M., Gabrielli, J., Powers, L. E., and Curry, M. A. (2011). Prevalence of interpersonal violence against community-living adults with disabilities: a literature review. Rehabil. Psychol. 56, 302–319. doi: 10.1037/a0025620
Humeniuk, R., Henry-Edwards, S., Ali, R., Poznyak, V., and Monteiro, M. G. (2010). The alcohol, Smoking and Substance involvement Screening Test (ASSIST): Manual for use in primary care. Available at: https://www.cabdirect.org/cabdirect/abstract/20133034036 (Accessed December 11, 2022).
Humphreys, J. (2003). Resilience in sheltered battered women. Issues Ment. Health Nurs. 24, 137–152. doi: 10.1080/01612840305293
Humphreys, C., Thiara, R. K., and Reagan, L. (2005). Domestic Violence and Substance Use: Overlapping Issues in Separate Services?. London: Greater London Authority.
Hyman, S. M., and Sinha, R. (2009). Stress-related factors in cannabis use and misuse: implications for prevention and treatment. J. Subst. Abus. Treat. 36, 400–413. doi: 10.1016/j.jsat.2008.08.005
Iguchi, M. Y., Bell, J., Ramchand, R. N., and Fain, T. (2005). How criminal system racial disparities may translate into health disparities. J. Health Care Poor Underserved 16, 48–56. doi: 10.1353/hpu.2005.0114
Iovine-Wong, P. E., Nichols-Hadeed, C., Thompson Stone, J., Gamble, S., Cross, W., Cerulli, C., et al. (2019). Intimate partner violence, suicide, and their overlapping risk in women veterans: a review of the literature. Mil. Med. 184, e201–e210. doi: 10.1093/milmed/usy355
Iverson, K. M., and Pogoda, T. K. (2015). Traumatic brain injury among women veterans: an invisible wound of intimate partner violence. Med. Care 53, S112–S119. doi: 10.1097/MLR.0000000000000263
Iverson, K. M., Sayer, N. A., Meterko, M., Stolzmann, K., Suri, P., Gormley, K., et al. (2020). Intimate partner violence among female OEF/OIF/OND veterans who were evaluated for traumatic brain injury in the veterans health administration: a preliminary investigation. J. Interpers. Violence 35, 2422–2445. doi: 10.1177/0886260517702491
Jackson, H., Philp, E., Nuttall, R. L., and Diller, L. (2002). Traumatic brain injury: a hidden consequence for battered women. Prof. Psychol. Res. Pract. 33, 39–45. doi: 10.1037/0735-7028.33.1.39
Johnson, D. M., and Zlotnick, C. (2009). HOPE for battered women with PTSD in domestic violence shelters. Prof. Psychol. Res. Pract. 40, 234–241. doi: 10.1037/a0012519
Kennedy, E., Heron, J., and Munafò, M. (2017). Substance use, criminal behaviour and psychiatric symptoms following childhood traumatic brain injury: findings from the ALSPAC cohort. Eur. Child Adolesc. Psychiatry 26, 1197–1206. doi: 10.1007/s00787-017-0975-1
Kilpatrick, D. G., Acierno, R., Resnick, H. S., Saunders, B. E., and Best, C. L. (1997). A 2-year longitudinal analysis of the relationships between violent assault and substance use in women. J. Consult. Clin. Psychol. 65, 834–847. doi: 10.1037//0022-006x.65.5.834
Kingery, P. M., Pruitt, B. E., and Hurley, R. S. (1992). Violence and illegal drug use among adolescents: evidence from the U.S. National Adolescent Student Health Survey. Int. J. Addict. 27, 1445–1464. doi: 10.3109/10826089209047362
Klostermann, K. C. (2006). Substance abuse and intimate partner violence: treatment considerations. Subst. Abuse Treat. Prev. Policy 1:24. doi: 10.1186/1747-597X-1-24
Kothari, C. L., and Rhodes, K. V. (2006). Missed opportunities: emergency department visits by police-identified victims of intimate partner violence. Ann. Emerg. Med. 47, 190–199. doi: 10.1016/j.annemergmed.2005.10.016
Kraanen, F. L., Vedel, E., Scholing, A., and Emmelkamp, P. M. G. (2014). Prediction of intimate partner violence by type of substance use disorder. J. Subst. Abus. Treat. 46, 532–539. doi: 10.1016/j.jsat.2013.10.010
Kubany, E. S., Hill, E. E., Owens, J. A., Iannce-Spencer, C., McCaig, M. A., Tremayne, K. J., et al. (2004). Cognitive trauma therapy for battered women with PTSD (CTT-BW). J. Consult. Clin. Psychol. 72, 3–18. doi: 10.1037/0022-006X.72.1.3
Kwako, L. E., Glass, N., Campbell, J., Melvin, K. C., Barr, T., and Gill, J. M. (2011). Traumatic brain injury in intimate partner violence: a critical review of outcomes and mechanisms. Trauma Violence Abuse 12, 115–126. doi: 10.1177/1524838011404251
La Flair, L. N., Bradshaw, C. P., Storr, C. L., Green, K. M., Alvanzo, A. A. H., and Crum, R. M. (2012). Intimate partner violence and patterns of alcohol abuse and dependence criteria among women: a latent class analysis. J. Stud. Alcohol Drugs 73, 351–360. doi: 10.15288/jsad.2012.73.351
Lake, S., and Kennedy, M. C. (2016). Health outcomes associated with illicit prescription opioid injection: a systematic review. J. Addict. Dis. 35, 73–91. doi: 10.1080/10550887.2015.1127712
Lehavot, K., Stappenbeck, C. A., Luterek, J. A., Kaysen, D., and Simpson, T. L. (2014). Gender differences in relationships among PTSD severity, drinking motives, and alcohol use in a comorbid alcohol dependence and PTSD sample. Psychol. Addict. Behav. 28, 42–52. doi: 10.1037/a0032266
LeTendre, M. L., and Reed, M. B. (2017). The effect of adverse childhood experience on clinical diagnosis of a substance use disorder: results of a nationally representative study. Subst. Use Misuse 52, 689–697. doi: 10.1080/10826084.2016.1253746
Lewis, B., Hoffman, L., Garcia, C. C., and Nixon, S. J. (2018). Race and socioeconomic status in substance use progression and treatment entry. J. Ethn. Subst. Abus. 17, 150–166. doi: 10.1080/15332640.2017.1336959
Leza, L., Siria, S., López-Goñi, J. J., and Fernández-Montalvo, J. (2021). Adverse childhood experiences (ACEs) and substance use disorder (SUD): a scoping review. Drug Alcohol Depend. 221:108563. doi: 10.1016/j.drugalcdep.2021.108563
Liebschutz, J., Savetsky, J. B., Saitz, R., Horton, N. J., Lloyd-Travaglini, C., and Samet, J. H. (2002). The relationship between sexual and physical abuse and substance abuse consequences. J. Subst. Abus. Treat. 22, 121–128. doi: 10.1016/s0740-5472(02)00220-9
Logan, T. K., and Walker, R. (2004). Separation as a risk factor for victims of intimate partner violence: beyond lethality and injury: a response to Campbell. J. Interpers. Violence 19, 1478–1486. doi: 10.1177/0886260504269699
Logan, T., Walker, R., Cole, J., and Leukefeld, C. (2002). Victimization and substance abuse among women: contributing factors, interventions, and implications. Rev. Gen. Psychol. 6, 325–397. doi: 10.1037/1089-2680.6.4.325
López-Fuentes, I., and Calvete, E. (2015). Building resilience: a qualitative study of Spanish women who have suffered intimate partner violence. Am. J. Orthopsychiatry 85, 339–351. doi: 10.1037/ort0000070
Lowe, D. J. E., Sasiadek, J. D., Coles, A. S., and George, T. P. (2019). Cannabis and mental illness: a review. Eur. Arch. Psychiatry Clin. Neurosci. 269, 107–120. doi: 10.1007/s00406-018-0970-7
Lutgendorf, M. A. (2019). Intimate partner violence and Women’s health. Obstet. Gynecol. 134, 470–480. doi: 10.1097/AOG.0000000000003326
Luthar, S. S., Cicchetti, D., and Becker, B. (2000). The construct of resilience: a critical evaluation and guidelines for future work. Child Dev. 71, 543–562. doi: 10.1111/1467-8624.00164
Macy, R. J., and Goodbourn, M. (2012). Promoting successful collaborations between domestic violence and substance abuse treatment service sectors: a review of the literature. Trauma Violence Abuse 13, 234–251. doi: 10.1177/1524838012455874
Macy, R. J., Renz, C., and Pelino, E. (2013). Partner violence and substance abuse are intertwined: Women’s perceptions of violence–substance connections. Violence Against Women 19, 881–902. doi: 10.1177/1077801213498208
Martino, S. C., Collins, R. L., and Ellickson, P. L. (2005). Cross-lagged relationships between substance use and intimate partner violence among a sample of young adult women. J. Stud. Alcohol 66, 139–148. doi: 10.15288/jsa.2005.66.139
Matsuzaka, S., and Knapp, M. (2020). Anti-racism and substance use treatment: addiction does not discriminate, but do we? J. Ethn. Subst. Abus. 19, 567–593. doi: 10.1080/15332640.2018.1548323
Mazza, M., Marano, G., Castillo, A. G. D., Chieffo, D., Monti, L., Janiri, D., et al. (2021). Intimate partner violence: a loop of abuse, depression and victimization. World J. Psychiatry 11, 215–221. doi: 10.5498/wjp.v11.i6.215
McFarlane, J., Soeken, K., Reel, S., Parker, B., and Silva, C. (1997). Resource use by abused women following an intervention program: associated severity of abuse and reports of abuse ending. Public Health Nurs. 14, 244–250. doi: 10.1111/j.1525-1446.1997.tb00297.x
McKee, S. A., and Hilton, N. Z. (2019). Co-occurring substance use, PTSD, and IPV victimization: implications for female offender services. Trauma Violence Abuse 20, 303–314. doi: 10.1177/1524838017708782
McKinley, C. E., and Theall, K. P. (2021). Weaving healthy families program: promoting resilience while reducing violence and substance use. Res. Soc. Work. Pract. 31, 476–492. doi: 10.1177/1049731521998441
McLean, G., and Bocinski, S. G. (2017). The economic cost of intimate partner violence, sexual assault, and stalking. Institute for Women’s Policy Research. Available at: https://iwpr.org/wp-content/uploads/2020/10/B367_Economic-Impacts-of-IPV-08.14.17.pdf (Accessed December 11, 2022).
McLellan, A. T. (2017). Substance misuse and substance use disorders: why do they matter in healthcare? Trans. Am. Clin. Climatol. Assoc. 128, 112–130.
Mennis, J., and Stahler, G. J. (2016). Racial and ethnic disparities in outpatient substance use disorder treatment episode completion for different substances. J. Subst. Abus. Treat. 63, 25–33. doi: 10.1016/j.jsat.2015.12.007
Merkel, S. F., Cannella, L. A., Razmpour, R., Lutton, E., Raghupathi, R., Rawls, S. M., et al. (2017). Factors affecting increased risk for substance use disorders following traumatic brain injury: what we can learn from animal models. Neurosci. Biobehav. Rev. 77, 209–218. doi: 10.1016/j.neubiorev.2017.03.015
Meyer, J. E., Jammula, V., and Arnett, P. A. (2021). Head trauma in a community-based sample of victims of intimate partner violence: prevalence, mechanisms of injury and symptom presentation. J. Interpers. Violence 37, NP15255–NP15274. doi: 10.1177/08862605211016362
Moore, T. M., Stuart, G. L., Meehan, J. C., Rhatigan, D. L., Hellmuth, J. C., and Keen, S. M. (2008). Drug abuse and aggression between intimate partners: a meta-analytic review. Clin. Psychol. Rev. 28, 247–274. doi: 10.1016/j.cpr.2007.05.003
Mueser, K. T., Noordsy, D. L., Drake, R. E., and Fox, L. (2003). Integrated Treatment for Dual Disorders: A Guide to Effective Practice. New York, NY: The Guilford Press.
Murphy, C. M., and Ting, L. (2010). The effects of treatment for substance use problems on intimate partner violence: a review of empirical data. Aggress. Violent Behav. 15, 325–333. doi: 10.1016/j.avb.2010.01.006
Najavits, L. M. (2007). “7- seeking safety: an evidence-based model for substance abuse and trauma/PTSD” in Therapist’s Guide to Evidence-Based Relapse Prevention. eds. K. A. Witkiewitz and G. A. Marlatt (Cambridge, MA: Academic Press), 141–167.
Najavits, L. M., and Hien, D. (2013). Helping vulnerable populations: a comprehensive review of the treatment outcome literature on substance use disorder and PTSD. J. Clin. Psychol. 69, 433–479. doi: 10.1002/jclp.21980
Najavits, L. M., Sonn, J., Walsh, M., and Weiss, R. D. (2004). Domestic violence in women with PTSD and substance abuse. Addict. Behav. 29, 707–715. doi: 10.1016/j.addbeh.2004.01.003
Nanayakkara, B., and McNamara, S. (2021). “Respiratory problems and substance misuse” in Textbook of Addiction Treatment: International Perspectives. eds. N. El-Guebaly, G. Carrà, M. Galanter, and A. M. Baldacchino (Cham: Springer International Publishing), 1045–1059. doi: 10.1007/978-3-030-36391-8_74
Nathanson, A. M., Shorey, R. C., Tirone, V., and Rhatigan, D. L. (2012). The prevalence of mental health disorders in a community sample of female victims of intimate partner violence. Partn. Abus. 3, 59–75. doi: 10.1891/1946-6560.3.1.59
National Institute of Justice (2016). Five Things About Violence Against American Indian and Alaska Native Women and Men. Washington, DC. U.S Department of Justice.
Neddenriep, B., Bagdas, D., Contreras, K. M., Ditre, J. W., Wolstenholme, J. T., Miles, M. F., et al. (2019). Pharmacological mechanisms of alcohol analgesic-like properties in mouse models of acute and chronic pain. Neuropharmacology 160:107793. doi: 10.1016/j.neuropharm.2019.107793
Nikoo, M., Gadermann, A., To, M. J, Krausz, M., Hwang, S. W., and Palepu, A. (2017). Incidence and associated risk factors of traumatic brain injury in a cohort of homeless and vulnerably housed adults in 3 Canadian cities. J. Head Trauma Rehabil. 32, E19–E26. doi: 10.1097/HTR.0000000000000262,
Niolon, P. H., Kearns, M., Dills, J., Rambo, K., Irviing, S., Armstead, T., et al. (2017). Preventing Intimate Partner Violence Across the Lifespan: A Technical Package of Programs, Policies, and Practices. National Center for Injury Prevention and Control, Centers for Disease Control and Prevention, Atlanta, GA.
Nowotny, K. M., and Graves, J. L. (2013). Substance use and intimate partner violence victimization among white, African American, and Latina women. J. Interpers. Violence 28, 3301–3318. doi: 10.1177/0886260513496903
Oakley, L. D., Luebke, J., Dosch, N. C., Snedden, T. R., Hernadez, H., Lemke, M., et al. (2021). Traumatic brain injury screening and the unmet health needs of shelter-seeking women with head injuries related to intimate partner violence. Womens Health Rep (New Rochelle). 2, 586–593. doi: 10.1089/whr.2021.0056
Ogden, S. N., Dichter, M. E., and Bazzi, A. R. (2022). Intimate partner violence as a predictor of substance use outcomes among women: a systematic review. Addict. Behav. 127:107214. doi: 10.1016/j.addbeh.2021.107214
Okuda, M., Olfson, M., Hasin, D., Grant, B. F., Lin, K.-H., and Blanco, C. (2011). Mental health of victims of intimate partner violence: results from a national epidemiologic survey. Psychiatr. Serv. 62, 959–962. doi: 10.1176/ps.62.8.pss6208_0959
Oliverio, R., Karelina, K., and Weil, Z. M. (2020). Sex, drugs, and TBI: the role of sex in substance abuse related to traumatic brain injuries. Front. Neurol. 11:546775. doi: 10.3389/fneur.2020.546775
Olsen, C. M., and Corrigan, J. D. (2021). Does TBI cause risky substance use or substance use disorder? Biol. Psychiatry 91, 421–437. doi: 10.1016/j.biopsych.2021.07.013
Olson-Madden, J. H., Brenner, L. A., Corrigan, J. D., Emrick, C. D., and Britton, P. C. (2012). Substance use and mild traumatic brain injury risk reduction and prevention: a novel model for treatment. Rehabil. Res. Pract. 2012:174579. doi: 10.1155/2012/174579
Oram, S., Fisher, H. L., Minnis, H., Seedat, S., Walby, S., Hegarty, K., et al. (2022). The lancet psychiatry commission on intimate partner violence and mental health: advancing mental health services, research, and policy. Lancet Psychiatry 9, 487–524. doi: 10.1016/S2215-0366(22)00008-6
Otiniano Verissimo, A. D., Gee, G. C., Ford, C. L., and Iguchi, M. Y. (2014). Racial discrimination, gender discrimination, and substance abuse among Latina/os nationwide. Cultur. Divers. Ethnic Minor. Psychol. 20, 43–51. doi: 10.1037/a0034674
Øverup, C. S., DiBello, A. M., Brunson, J. A., Acitelli, L. K., and Neighbors, C. (2015). Drowning the pain: intimate partner violence and drinking to cope prospectively predict problem drinking. Addict. Behav. 41, 152–161. doi: 10.1016/j.addbeh.2014.10.006
Owens, M. D., Hallgren, K. A., Ladd, B. O., Rynes, K., McCrady, B. S., and Epstein, E. (2013). Associations between relationship satisfaction and drinking urges for women in alcohol behavioral couples and individual therapy. Alcohol. Treat. Q. 31, 415–430. doi: 10.1080/07347324.2013.831668
Pagulayan, K. F., Temkin, N. R., Machamer, J. E., and Dikmen, S. S. (2016). Patterns of alcohol use after traumatic brain injury. J. Neurotrauma 33, 1390–1396. doi: 10.1089/neu.2015.4071
Pallatino, C., Chang, J. C., and Krans, E. E. (2019). The intersection of intimate partner violence and substance use among women with opioid use disorder. Subst. Abus. 42, 197–204. doi: 10.1080/08897077.2019.1671296
Paone, D., Chavkin, W., Willets, I., Friedmann, P., and Jarlais, D. D. (1992). The impact of sexual abuse: implications for drug treatment. J. Women's Health 1, 149–153. doi: 10.1089/jwh.1992.1.149
Patel, V., Chisholm, D., Parikh, R., Charlson, F. J., Degenhardt, L., Dua, T., et al. (2016). Addressing the burden of mental, neurological, and substance use disorders: key messages from disease control priorities. Lancet 387, 1672–1685. doi: 10.1016/S0140-6736(15)00390-6
Patrick, M. E., Evans-Polce, R. J., Parks, M. J., and Terry-McElrath, Y. M. (2021). Drinking intensity at age 29/30 as a predictor of alcohol use disorder symptoms at age 35 in a National Sample. J. Stud. Alcohol Drugs 82, 362–367. doi: 10.15288/jsad.2021.82.362
Peacock, A., Leung, J., Larney, S., Colledge, S., Hickman, M., Rehm, J., et al. (2018). Global statistics on alcohol, tobacco and illicit drug use: 2017 status report. Addiction 113, 1905–1926. doi: 10.1111/add.14234
Pico-Alfonso, M. A. (2005). Psychological intimate partner violence: the major predictor of posttraumatic stress disorder in abused women. Neurosci. Biobehav. Rev. 29, 181–193. doi: 10.1016/j.neubiorev.2004.08.010
Plummer, S.-B., and Findley, P. A. (2012). Women with disabilities’ experience with physical and sexual abuse: review of the literature and implications for the field. Trauma Violence Abuse 13, 15–29. doi: 10.1177/1524838011426014
Ponsford, J., Whelan-Goodinson, R., and Bahar-Fuchs, A. (2007). Alcohol and drug use following traumatic brain injury: a prospective study. Brain Inj. 21, 1385–1392. doi: 10.1080/02699050701796960
Poole, N., Greaves, L., Jategaonkar, N., McCullough, L., and Chabot, C. (2008). Substance use by women using domestic violence shelters. Subst. Use Misuse 43, 1129–1150. doi: 10.1080/10826080801914360
Priester, M. A., Browne, T., Iachini, A., Clone, S., DeHart, D., and Seay, K. D. (2016). Treatment access barriers and disparities among individuals with co-occurring mental health and substance use disorders: an integrative literature review. J. Subst. Abus. Treat. 61, 47–59. doi: 10.1016/j.jsat.2015.09.006
Pro, G., Sahker, E., and Marzell, M. (2018). Microaggressions and marijuana use among college students. J. Ethn. Subst. Abus. 17, 375–387. doi: 10.1080/15332640.2017.1288191
Rabin, R. F., Jennings, J. M., Campbell, J. C., and Bair-Merritt, M. H. (2009). Intimate partner violence screening tools: a systematic review. Am. J. Prev. Med. 36, 439–445.e4. doi: 10.1016/j.amepre.2009.01.024
Radcliffe, P., and Gilchrist, G. (2016). “You can never work with addictions in isolation”: addressing intimate partner violence perpetration by men in substance misuse treatment. Int. J. Drug Policy 36, 130–140. doi: 10.1016/j.drugpo.2016.03.010
Raith, K., and Hochhaus, G. (2004). Drugs used in the treatment of opioid tolerance and physical dependence: a review. Int. J. Clin. Pharmacol. Ther. 42, 191–203. doi: 10.5414/cpp42191
Rasmussen, V., Steel, Z., Spangaro, J., and Torok, M. (2021). Investigating the prevalence of intimate partner violence victimisation in women presenting to the emergency department in suicidal crisis. Emerg. Med. Australas. 33, 703–710. doi: 10.1111/1742-6723.13714
Reingle, J. M., Staras, S. A. S., Jennings, W. G., Branchini, J., and Maldonado-Molina, M. M. (2012). The relationship between marijuana use and intimate partner violence in a nationally representative, longitudinal sample. J. Interpers. Violence 27, 1562–1578. doi: 10.1177/0886260511425787
Rhodes, K. V., Kothari, C. L., Dichter, M., Cerulli, C., Wiley, J., and Marcus, S. (2011). Intimate partner violence identification and response: time for a change in strategy. J. Gen. Intern. Med. 26, 894–899. doi: 10.1007/s11606-011-1662-4
Rogozea, L., Dinu, E. A., Constantin, D., and Leaşu, F.-G. (2020). Self-medicating for pain: a public health perspective. Am. J. Ther. 27, e387–e391. doi: 10.1097/MJT.0000000000001173
Rollero, C., and Speranza, F. (2020). Intimate partner violence and resilience: the experience of women in mother-Child assisted living centers. Int. J. Environ. Res. Public Health 17:8318. doi: 10.3390/ijerph17228318
Rosay, A. (2016). Violence Against American Indian and Alaska Native Women and Men. NIJ Journal 277, 38–45.
Russo, E. B., Guy, G. W., and Robson, P. J. (2007). Cannabis, pain, and sleep: lessons from therapeutic clinical trials of Sativex®, a cannabis-based medicine. Chem. Biodivers. 4, 1729–1743. doi: 10.1002/cbdv.200790150
Saleem, G. T., Fitzpatrick, J. M., Haider, M. N., and Valera, E. M. (2021). COVID-19-induced surge in the severity of gender-based violence might increase the risk for acquired brain injuries. SAGE Open Med. 9:20503121211050196. doi: 10.1177/20503121211050197
Salom, C. L., Williams, G. M., Najman, J. M., and Alati, R. (2015). Substance use and mental health disorders are linked to different forms of intimate partner violence victimisation. Drug Alcohol Depend. 151, 121–127. doi: 10.1016/j.drugalcdep.2015.03.011
Sani, A. I., and Pereira, D. (2020). Mothers as victims of intimate partner violence: the decision to leave or stay and resilience-oriented intervention. Soc. Sci. 9:174. doi: 10.3390/socsci9100174
Saunders, J. B., Aasland, O. G., Babor, T. F., de la Fuente, J. R., and Grant, M. (1993). Development of the alcohol use disorders identification test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption--II. Addiction 88, 791–804. doi: 10.1111/j.1360-0443.1993.tb02093.x
Schaefer, L. M., Howell, K. H., Sheddan, H. C., Napier, T. R., Shoemaker, H. L., and Miller-Graff, L. E. (2021). The road to resilience: strength and coping among pregnant women exposed to intimate partner violence. J. Interpers. Violence 36, 8382–8408. doi: 10.1177/0886260519850538
Schindler, A. G., Baskin, B., Juarez, B., Janet Lee, S., Hendrickson, R., Pagulayan, K., et al. (2021). Repetitive blast mild traumatic brain injury increases ethanol sensitivity in male mice and risky drinking behavior in male combat veterans. Alcohol. Clin. Exp. Res. 45, 1051–1064. doi: 10.1111/acer.14605
Schmidt, L. A., Ye, Y., Greenfield, T. K., and Bond, J. (2007). Ethnic disparities in clinical severity and services for alcohol problems: results from the National Alcohol Survey. Alcohol. Clin. Exp. Res. 31, 48–56. doi: 10.1111/j.1530-0277.2006.00263.x
Schneider, R., Burnette, M. L., Ilgen, M. A., and Timko, C. (2009). Prevalence and correlates of intimate partner violence victimization among men and women entering substance use disorder treatment. Violence Vict. 24, 744–756. doi: 10.1891/0886-6708.24.6.744
Sheridan, D. J., and Nash, K. R. (2007). Acute injury patterns of intimate partner violence victims. Trauma Violence Abuse 8, 281–289. doi: 10.1177/1524838007303504
Shiwalkar, N., Gregor, D., Fu, R., Bekker, A., and Hong Ye, J. (2017). Changes in alcohol-related behavior following an incident of traumatic brain injury. J. Trauma Treat. 6, 1–7. doi: 10.4172/2167-1222.1000392
Simmons, C. A., Delaney, M. J., Lindsey, L., Whalley, A., Murry-Drobot, O., and Gayle Beck, J. (2017). Should programs designed to help IPV survivors screen for mental health-related problems: voices from the Field. Violence Against Women 23, 603–622. doi: 10.1177/1077801216646225
Simmons, C. A., Whalley, A., and Beck, J. G. (2014). Use of mental health screening instruments by non-medical helping professionals: a needs assessment. J. Interpers. Violence. 29, 2068–2090. doi: 10.1177/0886260513516386
Simonelli, A., Pasquali, C. E., and De Palo, F. (2014). Intimate partner violence and drug-addicted women: from explicative models to gender-oriented treatments. Eur. J. Psychotraumatol. 5:24496. doi: 10.3402/ejpt.v5.24496
Skinner, H. A. (1982). The drug abuse screening test. Addict. Behav. 7, 363–371. doi: 10.1016/0306-4603(82)90005-3
Smedley, B. D., Stith, A. Y., and Nelson, A. R. (2003). Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care. Washington, DC: National Academies Press.
Smith, P. H., Homish, G. G., Leonard, K. E., and Cornelius, J. R. (2012). Intimate partner violence and specific substance use disorders: findings from the National Epidemiologic Survey on alcohol and related conditions. Psychol. Addict. Behav. 26, 236–245. doi: 10.1037/a0024855
Smith, S. G., Zhang, X., Basile, K. C., Merrick, M. T., Wang, J., Kresnow, M., et al. (2018). The National Intimate Partner and sexual violence survey: 2015 data brief — Updated release. Atlanta, GA: National Center for Injury Prevention and Control, Centers for Disease Control and Prevention.
St Ivany, A., and Schminkey, D. (2016). Intimate partner violence and traumatic brain injury: state of the science and next steps. Fam. Community Health 39, 129–137. doi: 10.1097/FCH.0000000000000094
Stene, L. E., Dyb, G., Tverdal, A., Jacobsen, G. W., and Schei, B. (2012). Intimate partner violence and prescription of potentially addictive drugs: prospective cohort study of women in the Oslo health study. BMJ Open 2:e000614. doi: 10.1136/bmjopen-2011-000614
Stoicescu, C., Ameilia, R., Irwanto,, Praptoraharjo, I., and Mahanani, M. (2019). Syndemic and synergistic effects of intimate partner violence, crystal methamphetamine, and depression on HIV sexual risk behaviors among women who inject drugs in Indonesia. J. Urban Health 96, 477–496. doi: 10.1007/s11524-019-00352-6
Stone, R., and Rothman, E. F. (2019). Opioid use and intimate partner violence: a systematic review. Curr. Epidemiol. Rep. 6, 215–230. doi: 10.1007/s40471-019-00197-2
Sullivan, T. P., Ashare, R. L., Jaquier, V., and Tennen, H. (2012). Risk factors for alcohol-related problems among victims of partner violence. Subst. Use Misuse 47, 673–685. doi: 10.3109/10826084.2012.658132
Sullivan, T. P., and Holt, L. J. (2008). PTSD symptom clusters are differentially related to substance use among community women exposed to intimate partner violence. J. Trauma. Stress. 21, 173–180. doi: 10.1002/jts.20318
Sullivan, T. P., Weiss, N. H., Flanagan, J. C., Willie, T. C., Armeli, S., and Tennen, H. (2016). PTSD and daily co-occurrence of drug and alcohol use among women experiencing intimate partner violence. J. Dual Diagn. 12, 36–42. doi: 10.1080/15504263.2016.1146516
Testa, M., and Leonard, K. E. (2001). The impact of marital aggression on Women’s psychological and marital functioning in a newlywed sample. J. Fam. Violence 16, 115–130. doi: 10.1023/A:1011154818394
Testa, M., Livingston, J. A., and Leonard, K. E. (2003). Women’s substance use and experiences of intimate partner violence: a longitudinal investigation among a community sample. Addict. Behav. 28, 1649–1664. doi: 10.1016/j.addbeh.2003.08.040
Thompson, T., Oram, C., Correll, C. U., Tsermentseli, S., and Stubbs, B. (2017). Analgesic effects of alcohol: a systematic review and meta-analysis of controlled experimental studies in healthy participants. J. Pain 18, 499–510. doi: 10.1016/j.jpain.2016.11.009
Timko, C., Finney, J. W., and Moos, R. H. (2005). The 8-year course of alcohol abuse: gender differences in social context and coping. Alcohol. Clin. Exp. Res. 29, 612–621. doi: 10.1097/01.ALC.0000158832.07705.22
Tol, W. A., Murray, S. M., Lund, C., Bolton, P., Murray, L. K., Davies, T., et al. (2019). Can mental health treatments help prevent or reduce intimate partner violence in low-and middle-income countries? A systematic review. BMC Women’s Health 19:34. doi: 10.1186/s12905-019-0728-z
Tsirigotis, K., and Łuczak, J. (2018). Resilience in women who experience domestic violence. Psychiatry Q. 89, 201–211. doi: 10.1007/s11126-017-9529-4
Ullman, S. E., and Sigurvinsdottir, R. (2015). Intimate partner violence and drinking among victims of adult sexual assault. J. Aggress. Maltreat. Trauma 24, 117–130. doi: 10.1080/10926771.2015.996312
USDHHS (2020). Understanding Substance Use Coercion as a Barrier to Economic Stability for Survivors of Intimate Partner Violence: Policy Implications. Office of the Assistant Secretary for Planning and Evaluation and the Family and Youth Services Bureau, Division of Family Violence Prevention and Services, Washington, DC.
Valera, E. M., and Berenbaum, H. (2003). Brain injury in battered women. J. Consult. Clin. Psychol. 71, 797–804. doi: 10.1037/0022-006X.71.4.797
Valera, E. M., Cao, A., Pasternak, O., Shenton, M. E., Kubicki, M., Makris, N., et al. (2019). White matter correlates of mild traumatic brain injuries in women subjected to intimate-partner violence: a preliminary study. J. Neurotrauma 36, 661–668. doi: 10.1089/neu.2018.5734
Valera, E. M., Daugherty, J. C., Scott, O. C., and Berenbaum, H. (2022). Strangulation as an acquired brain injury in intimate-partner violence and its relationship to cognitive and psychological functioning: a preliminary study. J. Head Trauma Rehabil. 37, 15–23. doi: 10.1097/HTR.0000000000000755
Valera, E., and Kucyi, A. (2017). Brain injury in women experiencing intimate partner-violence: neural mechanistic evidence of an “invisible” trauma. Brain Imaging Behav. 11, 1664–1677. doi: 10.1007/s11682-016-9643-1
Volkow, N. D., Jones, E. B., Einstein, E. B., and Wargo, E. M. (2019). Prevention and treatment of opioid misuse and addiction: a review. JAMA Psychiat. 76, 208–216. doi: 10.1001/jamapsychiatry.2018.3126
Voon, P., Greer, A. M., Amlani, A., Newman, C., Burmeister, C., and Buxton, J. A. (2018). Pain as a risk factor for substance use: a qualitative study of people who use drugs in British Columbia, Canada. Harm. Reduct. J. 15:35. doi: 10.1186/s12954-018-0241-y
Voth Schrag, R. (2017). Campus based sexual assault and dating violence: a review of study contexts and participants. Affilia 32, 67–80. doi: 10.1177/0886109916644644
Vungkhanching, M., Heinemann, A. W., Langley, M. J., Ridgely, M., and Kramer, K. M. (2007). Feasibility of a skills-based substance abuse prevention program following traumatic brain injury. J. Head Trauma Rehabil. 22, 167–176. doi: 10.1097/01.HTR.0000271117.19652.98
Waalen, J., Goodwin, M. M., Spitz, A. M., Petersen, R., and Saltzman, L. E. (2000). Screening for intimate partner violence by health care providers: barriers and interventions. Am. J. Prev. Med. 19, 230–237. doi: 10.1016/S0749-3797(00)00229-4
Wagner, K. D., Hudson, S. M., Latka, M. H., Strathdee, S. A., Thiede, H., Mackesy-Amiti, M. E., et al. (2009). The effect of intimate partner violence on receptive syringe sharing among young female injection drug users: an analysis of mediation effects. AIDS Behav. 13, 217–224. doi: 10.1007/s10461-007-9309-5
Walker, N., Beek, K., Chen, H., Shang, J., Stevenson, S., Williams, K., et al. (2022). The experiences of persistent pain among women with a history of intimate partner violence: a systematic review. Trauma Violence Abuse 23, 490–505. doi: 10.1177/1524838020957989
Warsaw, C., and Tinnon, E. (2018). Coercion Related to Mental Health and Substance Use in the Context of Intimate Partner Violence: a Toolkit for Screening, Assessment, and Brief Counseling in Primary Care and Behavioral Health Settings. Chicago IL, USA: National Center on Domestic Violence, Trauma, & Mental Health.
Weil, Z. M., Corrigan, J. D., and Karelina, K. (2016). Alcohol abuse after traumatic brain injury: experimental and clinical evidence. Neurosci. Biobehav. Rev. 62, 89–99. doi: 10.1016/j.neubiorev.2016.01.005
Weinsheimer, R. L., Schermer, C. R., Malcoe, L. H., Balduf, L. M., and Bloomfield, L. A. (2005). Severe intimate partner violence and alcohol use among female trauma patients. J. Trauma 58, 22–29. doi: 10.1097/01.ta.0000151180.77168.a6
Werner-Wilson, R. J., Zimmerman, T. S., and Whalen, D. (2000). Resilient response to battering. Contemp. Fam. Ther. 22, 161–188. doi: 10.1023/A:1007777702757
WHO. (2013). Global and regional estimates of violence against women: Prevalence and health effects of intimate partner violence and non-partner sexual violence. Geneva: World Health Organization.
Wilbur, L., Higley, M., Hatfield, J., Surprenant, Z., Taliaferro, E., Smith, D. J., et al. (2001). Survey results of women who have been strangled while in an abusive relationship. J. Emerg. Med. 21, 297–302. doi: 10.1016/s0736-4679(01)00398-5
Williams, J. R., Girdler, S., Williams, W., and Cromeens, M. G. (2020). The effects of co-occurring interpersonal trauma and gender on opioid use and misuse. J. Interpers. Violence 36, NP13185–NP13205. doi: 10.1177/0886260519900309
Woods, S. J., Hall, R. J., Campbell, J. C., and Angott, D. M. (2008). Physical health and posttraumatic stress disorder symptoms in women experiencing intimate partner violence. J. Midwifery Womens Health 53, 538–546. doi: 10.1016/j.jmwh.2008.07.004
Wuest, J., Ford-Gilboe, M., Merritt-Gray, M., Wilk, P., Campbell, J. C., Lent, B., et al. (2010). Pathways of chronic pain in survivors of intimate partner violence. J. Women's Health 19, 1665–1674. doi: 10.1089/jwh.2009.1856
Wuest, J., Merritt-Gray, M., Ford-Gilboe, M., Lent, B., Varcoe, C., and Campbell, J. C. (2008). Chronic pain in women survivors of intimate partner violence. J. Pain 9, 1049–1057. doi: 10.1016/j.jpain.2008.06.009
Yamashita, A., Yoshioka, S., and Yajima, Y. (2021). Resilience and related factors as predictors of relapse risk in patients with substance use disorder: a cross-sectional study. Subst. Abuse Treat. Prev. Policy 16:40. doi: 10.1186/s13011-021-00377-8
Yoo, H. C., Gee, G. C., Lowthrop, C. K., and Robertson, J. (2010). Self-reported racial discrimination and substance use among Asian Americans in Arizona. J. Immigr. Minor. Health 12, 683–690. doi: 10.1007/s10903-009-9306-z
Younger, J., Barelka, P., Carroll, I., Kaplan, K., Chu, L., Prasad, R., et al. (2008). Reduced cold pain tolerance in chronic pain patients following opioid detoxification. Pain Med. 9, 1158–1163. doi: 10.1111/j.1526-4637.2008.00475.x
Keywords: substance misuse, interpersonal violence, brain injury, resilience, mood disorders
Citation: Mehr JB, Bennett ER, Price JL, de Souza NL, Buckman JF, Wilde EA, Tate DF, Marshall AD, Dams-O'Connor K and Esopenko C (2023) Intimate partner violence, substance use, and health comorbidities among women: A narrative review. Front. Psychol. 13:1028375. doi: 10.3389/fpsyg.2022.1028375
Edited by:
Andrea Poli, University of Pisa, ItalyReviewed by:
Glenna Tinney, Consultant, Alexandria, VA, United StatesGwen Hunnicutt, University of North Carolina at Greensboro, United States
Copyright © 2023 Mehr, Bennett, Price, De Souza, Buckman, Wilde, Tate, Marshall, Dams-O'Connor and Esopenko. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Carrie Esopenko, ✉ Carrie.Esopenko@mountsinai.org
†These authors share first authorship